1LEE A,FAGAN D,LAMONT M,et al.Disposition kinetics of ropivacaine in humans[J].Anesth Analg,1989,66(6):736-738.
2EMANUELSSON B M,ZARIC D,NYDAHL P A,et al.Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers[J].Anesth Analg,1995,81:1 163-1 168.
3GOEN K,MANTEL M,ZEIJLMANS P W M,et al.Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates[J].Anesth Analg,1998,86(2):361-366.
4BADER A M,TSEN L C,CAMANN W R,et al.Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery[J].Anesthesiology,1999,90(6):1596-1601.
5BADER A M,DATTA S,FLANAGAN H,et al.Comparison of bupivacaine and ropivacaine induced conduction blockade in the isolated rabbit vagus nerve[J].Ancsth Analg,1989,68(6):724-727.
6ODA A,OHASH H,KOMORI S,et al.Characteristics of ropivacaine block of Na channels in rat dorsal root ganglion neurons[J].Anesth Analg,2000,91(5):1213-1217.
7CEDERHOLM I,ACKEMAN B,EVERS H.Local analgesic and vascular effects of intrademal ropivacaine and bupivacaine in various concentrations with and without adrenaline in man[J].Acta Anaesthesiol Scand,1994,38:322-327.
8ZARIC D,NYDAHL P A,PHILIPSON L,et al.The effect of continuous lumbar epidural infusion of ropivacaine(0.1%,0.2% and 0.3 %)and 0.25% bupivacaine on sensory and motor block in volunteers[J].Reg Anesth,1996,21:14-23.
9OHMURA S,KAWADA M,OHTA T,et al.Systemic toxicity and resuscitation in bupivacaine,levobupivacaine or ropivacaine infused rats[J].Anesth Analg,2001,93(3):743-749.
10SZTARK F,NOUETTE G K,MALGAT M.Absence of stereospecific effects of bupivacaine isomers on heart mitochondrial bioenergetics[J].Anesthesiology,2000,93(2):456-462.
二级参考文献12
1Svensson LG, Klepp P, Hinder RA. Spinal cord anatomy of the baboon: comparison with man and implications of spinal cord blood flow during thoracic aortic cross-clamping, A Aft J Surg, 1986, 24:32-34.
2Krause GS, White BC, Aust SD, et al. Brain cell death following ischmia and reperfusion: a proposed biochemical sequence. Crit Care Med, 1988,16:714-726.
3Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates on spinal cord function after temporary thoracic aortic occlusion. J Neurosci, 1984, 4:1884-1891.
4Coombs DW. Management of chronic pain by epidural and intrathecal opioids: Newer drugs and delivery systems. Int Anesthesiol Clin, 1983, 24:59-74.
5Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine, 1985, 10: 777-781.
6Ishizake M, Sugiyama S, Uehida H, et al. Intrathecal oxygen concentration as a new indicator of spinal cord ischemia. Acta Med Okeyama 1997, 51: 71-77.
7Kroin JS, McCarthy, Kerns JM, et al. The effect of chronic subarachnoid bupivacaine infusion in dogs. Anesthesiology, 1987,66: 737-742.
8Grosby G. Local spinal cord blood flow and glucose utilization during spinal anesthesia with bupivacaine infusion in dogs. Anesthesiology,1987, 63: 55-60.
9Kristensen JD. Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg,1996, 82:636-640.
10Iida H, Ohata H, Iida M. Attenuated additional hypocapnic constriction, but not hypercapnic dilation, of spinal pial arterioles during spinal ropivacaine. Anesth Analg, 1999, 89:1510-1513.
